Pennell NA - Search Results

1

Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer: ECOG-ACRIN 5508.

Ramalingam SS, Dahlberg SE, Belani CP, Saltzman JN, Pennell NA, Nambudiri GS, McCann JC, Winegarden JD, Kassem MA, Mohamed MK, Rothman JM, Lyss AP, Horn L, Stinchcombe TE, Schiller JH. Ramalingam SS, et al. Among authors: pennell na. J Clin Oncol. 2019 Sep 10;37(26):2360-2367. doi: 10.1200/JCO.19.01006. Epub 2019 Jul 30. J Clin Oncol. 2019. PMID: 31361535 Free PMC article. Clinical Trial.

2

Investigational agents in the management of non-small cell lung cancer.

Pennell NA, Mekhail T. Pennell NA, et al. Curr Oncol Rep. 2009 Jul;11(4):275-84. doi: 10.1007/s11912-009-0039-x. Curr Oncol Rep. 2009. PMID: 19508832 Review.

3

Phase I study of the c-raf-1 antisense oligonucleotide ISIS 5132 in combination with carboplatin and paclitaxel in patients with previously untreated, advanced non-small cell lung cancer.

Fidias P, Pennell NA, Boral AL, Shapiro GI, Skarin AT, Eder JP Jr, Kwoh TJ, Geary RS, Johnson BE, Lynch TJ, Supko JG. Fidias P, et al. Among authors: pennell na. J Thorac Oncol. 2009 Sep;4(9):1156-62. doi: 10.1097/JTO.0b013e3181b2793f. J Thorac Oncol. 2009. PMID: 19704336 Free article. Clinical Trial.

4

Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

Zhu CQ, Ding K, Strumpf D, Weir BA, Meyerson M, Pennell N, Thomas RK, Naoki K, Ladd-Acosta C, Liu N, Pintilie M, Der S, Seymour L, Jurisica I, Shepherd FA, Tsao MS. Zhu CQ, et al. J Clin Oncol. 2010 Oct 10;28(29):4417-24. doi: 10.1200/JCO.2009.26.4325. Epub 2010 Sep 7. J Clin Oncol. 2010. PMID: 20823422 Free PMC article.

5

Integration of EGFR inhibitors and conventional chemotherapy in the treatment of non-small-cell lung cancer.

Pennell NA. Pennell NA. Clin Lung Cancer. 2011 Nov;12(6):350-9. doi: 10.1016/j.cllc.2011.03.029. Epub 2011 May 20. Clin Lung Cancer. 2011. PMID: 21723791 Review.

6

Selection of chemotherapy for patients with advanced non-small cell lung cancer.

Pennell NA. Pennell NA. Cleve Clin J Med. 2012 May;79 Electronic Suppl 1:eS46-50. doi: 10.3949/ccjm.78.s2.10. Cleve Clin J Med. 2012. PMID: 22614966 Free article.

7

Advanced non-small cell lung cancer (NSCLC): maintenance therapy for all?

Hashemi-Sadraei N, Pennell NA. Hashemi-Sadraei N, et al. Among authors: pennell na. Curr Treat Options Oncol. 2012 Dec;13(4):478-90. doi: 10.1007/s11864-012-0209-1. Curr Treat Options Oncol. 2012. PMID: 22972369

8

Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer.

Sharma N, Pennell N, Nickolich M, Halmos B, Ma P, Mekhail T, Fu P, Dowlati A. Sharma N, et al. Invest New Drugs. 2014 Apr;32(2):362-8. doi: 10.1007/s10637-013-0061-6. Epub 2014 Jan 15. Invest New Drugs. 2014. PMID: 24420556 Clinical Trial.

9

Understanding the Rationale for Immunotherapy in Non-Small Cell Lung Cancer.

Pennell NA. Pennell NA. Semin Oncol. 2015 Oct;42 Suppl 2:S3-10. doi: 10.1053/j.seminoncol.2015.09.016. Epub 2015 Sep 11. Semin Oncol. 2015. PMID: 26477472 Review.

10

Reduction of Inappropriate Prophylactic Pegylated Granulocyte Colony-Stimulating Factor Use for Patients With Non-Small-Cell Lung Cancer Who Receive Chemotherapy: An ASCO Quality Training Program Project of the Cleveland Clinic Taussig Cancer Institute.

Goodman LM, Moeller MB, Azzouqa AG, Guthrie AE, Dalby CK, Earl MA, Cheng C, Pennell NA, Shapiro M, Velcheti V, Stevenson JP. Goodman LM, et al. Among authors: pennell na. J Oncol Pract. 2016 Jan;12(1):e101-7. doi: 10.1200/JOP.2015.006502. J Oncol Pract. 2016. PMID: 26759474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page